scATACseq: Single-Cell ATAC Sequencing Analytical Validation (MD Anderson)
BRD ID: 3114
Tier: SOP
Source: CIMAC-CIDC Network
Number of times downloaded: 372
Description
This assay analytical validation and performance report describes the methods used to validate a single cell Assay for Transposase-Accessible Chromatin (ATAC) sequencing for the analysis of cryopreserved melanoma tumor cells and tumor infiltrating lymphocytes (TIL) isolated from patients diagnosed with metastatic melanoma. The document also presents data supporting the reported accuracy, precision, and analytical sensitivity. It is used by a Cancer Immune Monitoring and Analysis Center (CIMAC) at MD Anderson Cancer Center. It is a product of the CIMAC and Cancer Immunologic Data Center Network (CIMAC-CIDC Network; https://dctd.cancer.gov/research/networks/precision-medicine-oncology/cimac-cidc).
Biospecimens
CellSkin
CellWhite Cells
Diagnoses
NeoplasticMelanoma
Topics
Platform-specific Methodology